The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago

Gynecologic Oncology

Volumn 135, Issue 2, 2014, Pages 285-291

  Joslin, Charlotte E ^a   Brewer, Katherine C ^a   Davis, Faith G ^b   Hoskins, Kent ^a   Peterson, Caryn E ^a   Pauls, Heather A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Abbreviations; Black; NHB; NHW; Non Hispanic; Ovarian cancer; OVCA; White

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEIGHBORHOOD; OVARY CARCINOMA; PATIENT COMPLIANCE; RACE DIFFERENCE; SOCIAL STATUS; UNITED STATES; AFRICAN AMERICAN; CAUCASIAN; DEMOGRAPHY; EPIDEMIOLOGY; HEALTH CARE DISPARITY; ILLINOIS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARIECTOMY; PATHOLOGY; PELVIS EXENTERATION; PRACTICE GUIDELINE; PROTOCOL COMPLIANCE; SOCIAL CLASS; STATISTICS AND NUMERICAL DATA; UTILIZATION;

AFRICAN AMERICANS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHICAGO; CYTOREDUCTION SURGICAL PROCEDURES; EPIDEMIOLOGIC METHODS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GUIDELINE ADHERENCE; HEALTHCARE DISPARITIES; HUMANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARIECTOMY; PELVIC EXENTERATION; PRACTICE GUIDELINES AS TOPIC; RESIDENCE CHARACTERISTICS; SOCIAL CLASS;

EID: 84914107022     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.08.029     Document Type: Article

References (85)

1. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics CA Cancer J Clin 64 2014 9 29
2. G. Parham, J.L. Phillips, M.L. Hicks, N. Andrews, W.B. Jones, and H.M. Shingleton The National Cancer Data Base report on malignant epithelial ovarian carcinoma in African-American women Cancer 80 1997 816 826
3. J.K. Chan, M. Zhang, J.M. Hu, J.Y. Shin, K. Osann, and D.S. Kapp Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States J Surg Oncol 97 2008 103 107
4. X.L. Du, C.C. Sun, M.R. Milam, D.C. Bodurka, and S. Fang Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer Int J Gynecol Cancer 18 2008 660 669
5. R.E. Bristow, M.A. Powell, N. Al-Hammadi, L. Chen, J.P. Miller, and P.Y. Roland Disparities in ovarian cancer care quality and survival according to race and socioeconomic status J Natl Cancer Inst 105 2013 823 832
6. S. Kim, T.A. Dolecek, and F.G. Davis Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach Soc Sci Med 71 2010 274 281
7. V. McGuire, L. Herrinton, and A.S. Whittemore Race, epithelial ovarian cancer survival, and membership in a large health maintenance organization Epidemiology 13 2002 231 234
8. V. McGuire, C.A. Jesser, and A.S. Whittemore Survival among U.S. women with invasive epithelial ovarian cancer Gynecol Oncol 84 2002 399 403
9. R.E. Bristow, S. Ueda, M.A. Gerardi, O.B. Ajiboye, and O.A. Ibeanu Analysis of racial disparities in stage IIIC epithelial ovarian cancer care and outcomes in a tertiary gynecologic oncology referral center Gynecol Oncol 122 2011 319 323
10. M.T. Goodman, and Y.B. Shvetsov Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004 Cancer Epidemiol Biomarkers Prev 18 2009 132 139
11. J.S. Barnholtz-Sloan, M.A. Tainsky, J. Abrams, R.K. Severson, F. Qureshi, and S.M. Jacques Ethnic differences in survival among women with ovarian carcinoma Cancer 94 2002 1886 1893
12. M. Terplan, S. Temkin, A. Tergas, and E. Lengyel Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer Gynecol Oncol 111 2008 173 178
13. C.E. Peterson, G.H. Rauscher, T.P. Johnson, C.V. Kirschner, R.E. Barrett, and S. Kim The association between neighborhood socioeconomic status and ovarian cancer tumor characteristics Cancer Causes Control 25 2014 633 637
14. E.A. Howell, N. Egorova, M.P. Hayes, J. Wisnivesky, R. Franco, and N. Bickell Racial disparities in the treatment of advanced epithelial ovarian cancer Obstet Gynecol 122 2013 1025 1032
15. K.S. Albain, J.M. Unger, J.J. Crowley, C.A. Coltman Jr., and D.L. Hershman Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group J Natl Cancer Inst 101 2009 984 992
16. R.E. Bristow, J. Chang, A. Ziogas, L.M. Randall, and H. Anton-Culver High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease Gynecol Oncol 132 2014 403 410
17. J.M. Orsi, H. Margellos-Anast, and S. Whitman Black-White health disparities in the United States and Chicago: a 15-year progress analysis Am J Public Health 100 2010 349 356
18. D. Ansell, P. Grabler, S. Whitman, C. Ferrans, J. Burgess-Bishop, and L.R. Murray A community effort to reduce the black/white breast cancer mortality disparity in Chicago Cancer Causes Control 20 2009 1681 1688
19. S. Whitman, D. Ansell, J. Orsi, and T. Francois The racial disparity in breast cancer mortality J Community Health 36 2011 588 596
20. J.A. Jahn, C.F. Schmid, and C. Schrag The measurement of ecological segregation Am Sociol Rev 12 1947 293 303
21. S. Whitman, J. Orsi, and M. Hurlbert The racial disparity in breast cancer mortality in the 25 largest cities in the United States Cancer Epidemiol 36 2012 e147 e151
22. B.R. Hunt, S. Whitman, and M.S. Hurlbert Increasing Black:White disparities in breast cancer mortality in the 50 largest cities in the United States Cancer Epidemiol 38 2014 118 123
23. S.Y. Gebreab, and A.V. Diez Roux Exploring racial disparities in CHD mortality between blacks and whites across the United States: a geographically weighted regression approach Health Place 18 2012 1006 1014
24. S. Rosenstock, S. Whitman, J.F. West, and M. Balkin Racial disparities in diabetes mortality in the 50 most populous US cities. J Urban Health: Bull NY Acad Med 2014 [Epub ahead of print]
25. W.H. Frey New racial segregation measures for states and large metropolitan areas Analysis of the 2005-2009 American community survey and 2000 US census 2000 [Available from: http://censusscope.org/ACS/Segregation.html ]
26. J.L. Benedet, H. Bender, H. Jones III, H.Y. Ngan, and S. Pecorelli FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology Int J Gynaecol Obstet 70 2000 209 262
27. P. Venesmaa Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990 Obstet Gynecol 84 1994 8 11
28. L.A. Ries Ovarian cancer. Survival and treatment differences by age Cancer 71 1993 524 529
29. N. Einhorn, B. Nilsson, and K. Sjovall Factors influencing survival in carcinoma of the ovary. Study from a well-defined Swedish population Cancer 55 1985 2019 2025
30. H.R. Balvert-Locht, J.W. Coebergh, W.C. Hop, H.A. Brolmann, M. Crommelin, and D.J. van Wijck Improved prognosis of ovarian cancer in The Netherlands during the period 1975-1985: a registry-based study Gynecol Oncol 42 1991 3 8
31. T. Hogberg, B. Glimelius, and P. Nygren A systematic overview of chemotherapy effects in ovarian cancer Acta Oncol 40 2001 340 360
32. T. Bjorge, A. Engeland, K. Sundfor, and C.G. Trope Prognosis of 2,800 patients with epithelial ovarian cancer diagnosed during 1975-94 and treated at the Norwegian Radium Hospital Acta Obstet Gynecol Scand 77 1998 777 781
33. L.C. Harlan, L.X. Clegg, and E.L. Trimble Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States J Clin Oncol 21 2003 3488 3494
34. Illinios county cancer statistics review, 2006-2010 2013 Illinois Department of Public Health Springfiled, IL
35. J.L.J. Young, S.D. Roffers, L.A. Ries, A.G. Fritz, and A.A. Hurlbert SEER summary staging manual - 2000: codes and coding instructions 2001 National Cancer Institute Bethesda, MD
36. Illinois Department of Public Health Division of Epidemiologic Studies Illinois State Cancer Registry User manual Available from: http://www.idph.state.il.us/cancer/13/READMEv20.txt 2013
37. R. Farley Racial residential segregation, census 2000 findings Available from: http://enceladus.isr.umich.edu/race/racestart.asp March 25 2014
38. U.S. Census Bureau County population estimates, 100 largest counties. 2008 Available from: http://www.census.gov/popest/counties/CO-EST2008-07.html September 25 2009
39. Health Resources and Services Administration Find Shortage Areas: MUA/P by State and County US Department of Health and Human Services March 25 2014 [Available from: http://muafind.hrsa.gov/index.aspx ]
40. L.A. Baldwin, B. Huang, R.W. Miller, T. Tucker, S.T. Goodrich, and I. Podzielinski Ten-year relative survival for epithelial ovarian cancer Obstet Gynecol 120 2012 612 618
41. A.G. Fritz, C. Percy, A. Jack, K. Shanmugaratnam, L.H. Sobin, and D.M. Parkin International classification of disease for oncology 3rd ed. 2000 World Health Organization Geneva
42. Bureau of Health Information S, Research, and Evaluation;. Data Report: Ovarian Cancer in Massachusetts. In: Massachusetts Department of Public Health, editor.2010.
43. American College of Surgeons Commision on Cancer National Cancer Data Base PUF 2012 Available from: http://ncdbpuf.facs.org/ 2014 March 25
44. A.F. Grann, M. Norgaard, J. Blaakaer, E. Sogaard-Andersen, and J.B. Jacobsen Survival of patients with ovarian cancer in central and northern Denmark, 1998-2009 Clin Epidemiol 3 Suppl. 1 2011 59 64
45. C.D. O'Malley, R.D. Cress, S.L. Campleman, and G.S. Leiserowitz Survival of Californian women with epithelial ovarian cancer, 1994-1996: a population-based study Gynecol Oncol 91 2003 608 615
46. C.R. Browning, and K.A. Cagney Neighborhood structural disadvantage, collective efficacy, and self-rated physical health in an urban setting J Health Soc Behav 43 2002 383 399
47. R.J. Sampson, J.D. Morenoff, and F. Earls Beyond social capital: spatial dynamics of collective efficacy for children Am Soc Rev 64 1999 633 660
48. B. Hidalgo, and M. Goodman Multivariate or multivariable regression? Am J Public Health 103 2013 39 40
49. D.M. Chase, S. Fedewa, T.S. Chou, A. Chen, E. Ward, and W.R. Brewster Disparities in the allocation of treatment in advanced ovarian cancer: are there certain patient characteristics associated with nonstandard therapy? Obstet Gynecol 119 2012 68 77
50. National Institutes of Health Consensus Development Conference Statement Ovarian cancer: screening, treatment, and follow-up Gynecol Oncol 55 1994 S4 S14
51. D.K. Armstrong, B. Bundy, L. Wenzel, H.Q. Huang, R. Baergen, and S. Lele Intraperitoneal cisplatin and paclitaxel in ovarian cancer N Engl J Med 354 2006 34 43
52. G.D. Aletti, D. Nordquist, L. Hartmann, M. Gallenberg, H.J. Long, and W.A. Cliby From randomized trial to practice: single institution experience using the GOG 172 i.p. chemotherapy regimen for ovarian cancer Ann Oncol 21 2010 1772 1778
53. R.W. Naumann, P. Sukumvanich, and R.P. Edwards Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer Gynecol Oncol 114 2009 37 41
54. J.B. Yu, C.P. Gross, L.D. Wilson, and B.D. Smith NCI SEER public-use data: applications and limitations in oncology research Oncology (Williston Park) 23 2009 288 295
55. D.P. Winchester, A.K. Stewart, J.L. Phillips, and E.E. Ward The national cancer data base: past, present, and future Ann Surg Oncol 17 2010 4 7
56. R.B. Warnecke, A. Oh, N. Breen, S. Gehlert, E. Paskett, and K.L. Tucker Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities Am J Public Health 98 2008 1608 1615
57. F. Islami, A.R. Kahn, N.A. Bickell, M.J. Schymura, and P. Boffetta Disentangling the effects of race/ethnicity and socioeconomic status of neighborhood in cancer stage distribution in New York City Cancer Causes Control 24 2013 1069 1078
58. M. Sogaard, R.W. Thomsen, K.S. Bossen, H.T. Sorensen, and M. Norgaard The impact of comorbidity on cancer survival: a review Clin Epidemiol 5 2013 3 29
59. A. Berglund, A. Wigertz, J. Adolfsson, J. Ahlgren, T. Fornander, and F. Warnberg Impact of comorbidity on management and mortality in women diagnosed with breast cancer Breast Cancer Res Treat 135 2012 281 289
60. L.H. Iversen, M. Norgaard, J. Jacobsen, S. Laurberg, and H.T. Sorensen The impact of comorbidity on survival of Danish colorectal cancer patients from 1995 to 2006-a population-based cohort study Dis Colon Rectum 52 2009 71 78
61. M. Luchtenborg, E. Jakobsen, M. Krasnik, K.M. Linklater, A. Mellemgaard, and H. Moller The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients Eur J Cancer 48 2012 3386 3395
62. A.L. Rich, L.J. Tata, C.M. Free, R.A. Stanley, M.D. Peake, and D.R. Baldwin How do patient and hospital features influence outcomes in small-cell lung cancer in England? Br J Cancer 105 2011 746 752
63. S. Cykert, P. Dilworth-Anderson, M.H. Monroe, P. Walker, F.R. McGuire, and G. Corbie-Smith Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer J Am Med Assoc 303 2010 2368 2376
64. G.D. Kennedy, V. Rajamanickam, E.S. O'Connor, N.K. Loconte, E.F. Foley, and G. Leverson Optimizing surgical care of colon cancer in the older adult population Ann Surg 253 2011 508 514
65. S. Houterman, M.L. Janssen-Heijnen, C.D. Verheij, W.J. Louwman, G. Vreugdenhil, and M.J. van der Sangen Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients Br J Cancer 90 2004 2332 2337
66. N.M. Rueth, H.M. Parsons, E.B. Habermann, S.S. Groth, B.A. Virnig, and T.M. Tuttle Surgical treatment of lung cancer: predicting postoperative morbidity in the elderly population J Thorac Cardiovasc Surg 143 2012 1314 1323
67. E.J. Morris, E.F. Taylor, J.D. Thomas, P. Quirke, P.J. Finan, and M.P. Coleman Thirty-day postoperative mortality after colorectal cancer surgery in England Gut 60 2011 806 813
68. B.L. Van Leeuwen, K.M. Rosenkranz, L.L. Feng, I. Bedrosian, K. Hartmann, and K.K. Hunt The effect of under-treatment of breast cancer in women 80 years of age and older Crit Rev Oncol Hematol 79 2011 315 320
69. L.N. van Steenbergen, H.J. Rutten, G.J. Creemers, J.F. Pruijt, J.W. Coebergh, and V.E. Lemmens Large age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in southern Netherlands Ann Oncol 21 2010 1273 1278
70. C.J. Bradley, C.W. Given, B. Dahman, and T.L. Fitzgerald Adjuvant chemotherapy after resection in elderly Medicare and Medicaid patients with colon cancer Arch Intern Med 168 2008 521 529
71. R. Luo, S.H. Giordano, J.L. Freeman, D. Zhang, and J.S. Goodwin Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer Oncologist 11 2006 1025 1033
72. C.P. Gross, Z. Guo, G.J. McAvay, H.G. Allore, M. Young, and M.E. Tinetti Multimorbidity and survival in older persons with colorectal cancer J Am Geriatr Soc 54 2006 1898 1904
73. S.W. Gray, M.B. Landrum, E.B. Lamont, B.J. McNeil, M.T. Jaklitsch, and N.L. Keating Improved outcomes associated with higher surgery rates for older patients with early stage nonsmall cell lung cancer Cancer 118 2012 1404 1411
74. L.M. Pasetto, C. Falci, U. Basso, G. Gasparini, M. D'Andrea, and P. Bonginelli Adjuvant treatment for elderly patients with colon cancer. An observational study Anticancer Res 28 2008 2513 2518
75. S.M. Dy, P. Sharkey, R. Herbert, K. Haddad, and A.W. Wu Comorbid illnesses and health care utilization among Medicare beneficiaries with lung cancer Crit Rev Oncol Hematol 59 2006 218 225
76. C.M. Booth, F.A. Shepherd, Y. Peng, G. Darling, G. Li, and W. Kong Adjuvant chemotherapy for non-small cell lung cancer: practice patterns and outcomes in the general population of Ontario, Canada J Thorac Oncol 7 2012 559 566
77. B.H. Gronberg, S. Sundstrom, S. Kaasa, R.M. Bremnes, O. Flotten, and T. Amundsen Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy Eur J Cancer 46 2010 2225 2234
78. C.Y. Hu, G.L. Delclos, W. Chan, and X.L. Du Assessing the initiation and completion of adjuvant chemotherapy in a large nationwide and population-based cohort of elderly patients with stage-III colon cancer Med Oncol 28 2011 1062 1074
79. H.A. Maas, R.F. Kruitwagen, V.E. Lemmens, S.H. Goey, and M.L. Janssen-Heijnen The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study Gynecol Oncol 97 2005 104 109
80. T.L. Jorgensen, S. Teiblum, M. Paludan, L.O. Poulsen, A.Y. Jorgensen, and K.H. Bruun Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients Gynecol Oncol 127 2012 367 374
81. M.S. Tetsche, C. Dethlefsen, L. Pedersen, H.T. Sorensen, and M. Norgaard The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study BMC Cancer 8 2008 31
82. S. Tingulstad, F.E. Skjeldestad, T.B. Halvorsen, and B. Hagen Survival and prognostic factors in patients with ovarian cancer Obstet Gynecol 101 2003 885 891
83. P. DiSilvestro, J.F. Peipert, J.W. Hogan, and C.O. Granai Prognostic value of clinical variables in ovarian cancer J Clin Epidemiol 50 1997 501 505
84. E.H. Shinn, D.J. Lenihan, D.L. Urbauer, K.M. Basen-Engquist, A. Valentine, and L. Palmero Impact of cardiovascular comorbidity on ovarian cancer mortality Cancer Epidemiol Biomarkers Prev 22 2013 2102 2109 [cosponsored by the American Society of Preventive Oncology]
85. R.E. Bristow, B.E. Palis, D.S. Chi, and W.A. Cliby The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm Gynecol Oncol 118 2010 262 267